[PDF][PDF] A systematic overview of radiation therapy effects in prostate cancer

S Nilsson, BJ Norlén, A Widmark - Acta Oncologica, 2004 - Citeseer
A systematic review of radiation therapy trials in prostate cancer has been performed
according to principles adopted by the Swedish Council of Technology Assessment in …

Evidence-based review of three-dimensional conformal radiotherapy for localized prostate cancer: an ASTRO outcomes initiative

DE Morris, B Emami, PM Mauch, AA Konski… - International Journal of …, 2005 - Elsevier
Purpose: To perform a systematic review of the evidence to determine the efficacy and
effectiveness of three-dimensional conformal radiotherapy (3D-CRT) for localized prostate …

[HTML][HTML] Fractionation and protraction for radiotherapy of prostate carcinoma

DJ Brenner, EJ Hall - International Journal of Radiation Oncology* Biology …, 1999 - Elsevier
Purpose: To investigate whether current fractionation and brachytherapy protraction
schemes for the treatment of prostatic cancer with radiation are optimal, or could be …

Dose-response in radiotherapy for localized prostate cancer: results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy

STH Peeters, WD Heemsbergen… - Journal of Clinical …, 2006 - ascopubs.org
Purpose To determine whether a dose of 78 Gy improves outcome compared with a
conventional dose of 68 Gy for prostate cancer patients treated with three-dimensional …

Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer

MJ Zelefsky, SA Leibel, PB Gaudin, GJ Kutcher… - International Journal of …, 1998 - Elsevier
Purpose: Three-dimensional conformal radiation therapy (3D-CRT) is a technique designed
to deliver prescribed radiation doses to localized tumors with high precision, while effectively …

How low is the α/β ratio for prostate cancer?

JZ Wang, M Guerrero, XA Li - International Journal of Radiation Oncology …, 2003 - Elsevier
Purpose: It has been suggested recently that the α/β ratio for human prostate cancer is low
(around 1.5 Gy), and much debate on the evidence for such a low value is ongoing …

Dose escalation with 3D conformal treatment: five year outcomes, treatment optimization, and future directions

GE Hanks, AL Hanlon, TE Schultheiss… - International Journal of …, 1998 - Elsevier
Purpose: To report the 5-year outcomes of dose escalation with 3D conformal treatment
(3DCRT) of prostate cancer. Methods and Materials: Two hundred thirty-two consecutive …

Evaluating the effect of rectal distension and rectal movement on prostate gland position using cine MRI

AR Padhani, VS Khoo, J Suckling, JE Husband… - International Journal of …, 1999 - Elsevier
Purpose: To evaluate the dynamic interrelationship between rectal distension and rectal
movements, and to determine the effect of rectal movement on the position of the prostatic …

Palladium-103 brachytherapy for prostate carcinoma

JC Blasko, PD Grimm, JE Sylvester… - International Journal of …, 2000 - Elsevier
Purpose: A report of biochemical outcomes for patients treated with palladium-103 (Pd-103)
brachytherapy over a fixed time interval. Methods and Materials: Two hundred thirty patients …

Incorporating clinical measurements of hypoxia into tumor local control modeling of prostate cancer: implications for the α/β ratio

AE Nahum, B Movsas, EM Horwitz, CC Stobbe… - International Journal of …, 2003 - Elsevier
BACKGROUND AND PURPOSE: The recently obtained low value of∼ 1.5 for the α/β of
prostate cancer has led us to reexamine the optimal prostate tumor biology parameters …